Janssen has signed a deal with Forma Therapeutics to discover, and develop drugs that target tumour metabolism mechanisms.Forma focuses on …
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions

